Genotype and neuropsychological response inhibition as resilience promoters for attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct disorder under conditions of psychosocial adversity.
Whereas child personality, IQ, and family factors have been identified as enabling a resilient response to psychosocial adversity, more direct biological resilience factors have been less well delineated. This is particularly so for child attention-deficit/hyperactivity disorder (ADHD), which has received less attention from a resilience perspective than have associated externalizing disorders. Children from two independent samples were classified as resilient if they avoided developing ADHD, oppositional defiant disorder (ODD), or conduct disorder (CD) in the face of family adversity. Two protective factors were examined for their potential relevance to prefrontal brain development: neuropsychological response inhibition, as assessed by the Stop task, and a composite catecholamine genotype risk score. Resilient children were characterized in both samples by more effective response inhibition, although the effect in the second sample was very small. Genotype was measured in Sample 1, and a composite high risk genotype index was developed by summing presence of risk across markers on three genes expressed in prefrontal cortex: dopamine transporter, dopamine D4 receptor, and noradrenergic alpha-2 receptor. Genotype was a reliable resilience indicator against development of ADHD and CD, but not ODD, in the face of psychosocial adversity. Results illustrate potential neurobiological protective factors related to development of prefrontal cortex that may enable children to avoid developing ADHD and CD in the presence of psychosocial adversity.
Nigg
Joel
J
Department of Psychology, Michigan State University, East Lansing, MI 48824-1116, USA. nigg@msu.edu
Nikolas
Molly
M
Friderici
Karen
K
Park
Leeyoung
L
Zucker
Robert A
RA
D001289:Attention Deficit Disorder with Hyperactivity / Q000453:epidemiology* / Q000235:genetics*; D019958:Attention Deficit and Disruptive Behavior Disorders / Q000175:diagnosis / Q000453:epidemiology*; D002648:Child; D003072:Cognition Disorders / Q000175:diagnosis / Q000453:epidemiology*; D019955:Conduct Disorder / Q000175:diagnosis / Q000453:epidemiology*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000235:genetics*; D005190:Family / Q000523:psychology; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008393:Marriage / Q000523:psychology; D009483:Neuropsychological Tests; D016133:Polymerase Chain Reaction; D011584:Psychology; D050638:Receptors, Dopamine D4 / Q000235:genetics*; D012931:Social Environment
C493599:DRD4 protein, human; D050483:Dopamine Plasma Membrane Transport Proteins; C493214:SLC6A3 protein, human; D050638:Receptors, Dopamine D4
Fam Process. 1976 Dec;15(4):357-71
1026454
Br J Psychiatry. 1975 Jun;126:493-509
1174767
Mol Psychiatry. 2004 Jul;9(7):711-7
14699430
Fam Process. 2004 Mar;43(1):23-41
15359713
J Am Acad Child Adolesc Psychiatry. 1989 Nov;28(6):861-4
2808256
Can J Psychiatry. 1991 Aug;36(6):415-21
1933744
J Child Psychol Psychiatry. 1991 Sep;32(6):939-50
1744197
Child Dev. 1992 Jun;63(3):558-72
1600822
Am J Psychiatry. 1994 Nov;151(11):1673-85
7943460
J Am Acad Child Adolesc Psychiatry. 1994 Oct;33(8):1145-55; discussion 155-7
7982865
Arch Gen Psychiatry. 1995 Jun;52(6):464-70
7771916
Am J Hum Genet. 1995 Nov;57(5):1252-4
7485180
Arch Gen Psychiatry. 1995 Nov;52(11):916-24
7487340
Psychiatr Serv. 1996 Mar;47(3):293-7
8820554
Psychol Bull. 1997 Jan;121(1):65-94
9000892
Arch Gen Psychiatry. 1998 Apr;55(4):362-8
9554432
J Child Psychol Psychiatry. 1998 Mar;39(3):411-25
9670096
Dev Psychopathol. 1999 Winter;11(1):143-69
10208360
J Abnorm Psychol. 2004 Nov;113(4):603-13
15535792
J Child Psychol Psychiatry. 2005 Mar;46(3):327-36
15755308
Mol Psychiatry. 2005 Jun;10(6):572-80
15520832
Biol Psychiatry. 2005 Jun 1;57(11):1224-30
15949992
Biol Psychiatry. 2005 Jun 1;57(11):1313-23
15950004
J Am Acad Child Adolesc Psychiatry. 2005 Jul;44(7):690-8
15968238
Br J Psychiatry. 2005 Aug;187:103-5
16055819
Arch Gen Psychiatry. 2005 Aug;62(8):896-902
16061767
J Child Psychol Psychiatry. 2006 Mar-Apr;47(3-4):395-422
16492265
J Abnorm Child Psychol. 1999 Oct;27(5):393-402
10582840
Dev Psychopathol. 2000 Winter;12(1):91-106
10774598
Child Dev. 2000 May-Jun;71(3):543-62
10953923
Mol Psychiatry. 2000 Sep;5(5):531-6
11032387
J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):168-79
11211365
Biol Psychiatry. 2001 Feb 15;49(4):333-9
11239904
Am J Psychiatry. 2001 Nov;158(11):1884-90
11691696
Clin Child Fam Psychol Rev. 2001 Sep;4(3):183-207
11783738
J Am Acad Child Adolesc Psychiatry. 2002 Jan;41(1):59-66
11800208
Dev Psychobiol. 2002 Apr;40(3):237-54
11891636
J Abnorm Child Psychol. 2002 Feb;30(1):37-52
11930970
Psychol Methods. 2002 Jun;7(2):147-77
12090408
Child Dev. 2002 Jul-Aug;73(4):1085-100
12146735
Science. 2002 Aug 2;297(5582):851-4
12161658
Am J Psychiatry. 2002 Sep;159(9):1556-62
12202277
Acta Psychol (Amst). 2003 Feb;112(2):105-42
12521663
Nat Neurosci. 2003 Feb;6(2):115-6
12536210
Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):33-44
12732221
J Abnorm Child Psychol. 2003 Aug;31(4):381-97
12831228
Arch Gen Psychiatry. 1972 Jan;26(1):57-63
5009428
J Abnorm Psychol. 2004 May;113(2):302-14
15122950